Skip to main content
Log in

Diagnosis and Treatment of Primary Tumors of the Appendix: a Critical Review

  • Review Article
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Introduction

The aim of the current paper was to critically collect, select and summarize the evidence regarding diagnosis, treatment and follow up of primary tumors of the appendix.

Methods

A literature review was performed by search and review of the scientific studies pertaining to the subject of our inquiry.

Results

Recommendations regarding pimary tumors of the appendix were formulated on the basis of the collected evidence.

Conclusion 

Primary tumors of the appendix are rare and a high index of suspicion is required not to miss a potentially life threatening medical condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Moris D, Ntanasis-Stathopoulos I, Tsilimigras DI, Vagios S, Karamitros A, Karaolanis G, Griniatsos J, Papalampros A, Papaconstantinou I, Glantzounis GK, Spartalis E. Update on surgical management of small bowel neuroendocrine tumors. Anticancer Res. 2018;38(3):1267–78.

  2. Glasgow SC, Wolfgang G, Stewart D, et al. the american society of colon and rectal surgeons, clinical practice guidelines for the management of appendiceal neoplasms. Dis Colon Rectum. 2019;62:1425–38.

  3. Turaga KK, Pappas SG, Gamblin T. Importance of histologic subtype in the staging of appendiceal tumors. Ann Surg Oncol. 2012;19:1379–85.

  4. McCusker ME, Coté T, Clegg LX, Sobin LH. Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973–1998. Cancer. 2002;94:3307–12.

  5. Mesa H, Manivel J, Larson WS, Dachel SK, Reinink AR, Jessurun J. Immunophenotypic comparison of neoplasms of the appendix, right colon, and left colon in search of a site-specific phenotypic signature. Int J Surg Pathol. 202028:20–30.

  6. Son IT, Ahn S, Park KJ, et al. Comparison of long-term oncological outcomes of appendiceal cancer and colon cancer: a multicenter retrospective study. Surg Oncol. 2016;25:37–43.

  7. Shetty S, Natarajan B, Thomas P, Govindarajan V, Sharma, P, Loggie B. Proposed classification of pseudomyxoma peritonei: influence of signet ring cells on survival. Am Surg. 2013;79:1171–6.

  8. Brathwaite S, Rock J, Yearsley MM, et al. Mixed adeno-neuroendocrine carcinoma: an aggressive clinical entity. Ann Surg Oncol. 2016;23:2281–6.

  9. Marmor S, Portschy P, Tuttle TM, Virnig BA. The rise in appendiceal cancer incidence: 2000–2009. J Gastrointest Surg. 2015;19:743–50.

  10. Mällinen J, Rautio T, Grönroos J, et al. Risk of appendiceal neoplasm in periappendicular abscess in patients treated with interval appendectomy vs follow-up with magnetic resonance imaging: 1-year outcomes of the Peri-Appendicitis Acuta Randomized Clinical Trial. JAMA Surg. 2019;154:200–7.

  11. de Jonge J, Bolmers MDM, Musters GD, van Rossem CC, Bemelman WA, van Geloven AAW. Predictors for interval appendectomy in non-operatively treated complicated appendicitis. Int J Colorectal Dis. 2019;34:1325–32.

  12. Morano WF, Gleeson E, Sullivan SH, et al. Clinicopathological features and management of appendiceal mucoceles: a systematic review. Am Surg. 2018;84:273–81.

  13. Kim TK, Park JH, Kim JY, et al. Safety and feasibility of laparoscopic surgery for appendiceal mucocele: a multicenter study. Surg Endosc. 2018;32:4408–14.

  14. Khan MN, Moran BJ. Four percent of patients undergoing colorectal cancer surgery may have synchronous appendiceal neoplasia. Dis Colon Rectum. 2007;50: 1856–9.

  15. Munoz-Zuluaga CA, Armando S, MacDonald R, et al. The role of preoperative tumor markers in patients with peritoneal carcinomatosis from appendiceal cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2018l25:155–6.

  16. van Ruth S, Hart AAM, Bonfrer JM, Verwaal VJ, Zoetmulder FA. Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2002;9:961–7.

  17. Davison JM, Choudry H, Pingpank JF, et al. Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade. Mod Pathol. 2014;27: 1521–39.

  18. Choudry HA, Pai RK. Management of Mucinous Appendiceal Tumors. Ann Surg Oncol. 2018;25:2135–44.

  19. Guaglio M, Sinukumar S, Kusamura S, et al. Clinical surveillance after macroscopically complete surgery for low-grade appendiceal mucinous neoplasms (LAMN) with or without limited peritoneal spread: long-term results in a prospective series. Ann Surg Oncol. 2018;25:878–4.

  20. Govaerts K, Chandrakumaran K, Carr NJ, et al. Single centre guidelines for radiological follow-up based on 775 patients treated by cytoreductive surgery and HIPEC for appendiceal pseudomyxoma peritonei. Eur J Surg Oncol. 2018;44: 1371–7.

  21. Roxburgh CS, Fenig YM, Cercek A, et al. Outcomes of low-grade appendiceal mucinous neoplasms with remote acellular mucinous peritoneal deposits. Ann Surg Oncol. 2019;26: 118–24.

  22. Sugarbaker PH. When and when not to perform a right colon resection with mucinous appendiceal neoplasms. Ann Surg Oncol. 2017;24: 729–32.

  23. Nasseri YY, Zhu R, Sutanto C, Wai C, Cohen JS, Ellenhorn J, Artinyan A. Role of right hemicolectomy in patients with low-grade appendiceal mucinous adenocarcinoma. Am J Surg. 2019;218(6):1239–43.

  24. Sugarbaker PH. When and when not to perform a right colon resection with mucinous appendiceal neoplasms. Ann Surg Oncol. 2016;24:729–32.

    Article  Google Scholar 

  25. Nash GM, Smith JD, Tang L, et al. Lymph node metastasis predicts disease recurrence in a single-center experience of 70 stages 1–3 appendix cancers: a retrospective review. Ann Surg Oncol. 2015;22: 3613–7.

  26. Xie X, Zhou Z, Song Y, et al. The management and prognostic prediction of adenocarcinoma of appendix. Sci Rep. 2016;6(39027).

  27. Gahagan JV, Whealon M, Phelan MJ, et al. Lymph node positivity in appendiceal adenocarcinoma: should size matter? J Am Coll Surg. 2017;225(1):69–75.

  28. Rossi RE, Luong TV, Caplin ME, et al. Goblet cell appendiceal tumors–management dilemmas and long-term outcomes. Surg Oncol. 2015;24:47–53.

  29. González-Moreno S, Sugarbaker PH. Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg. 2004;91: 304–11.

  30. Shannon AB, Goldberg D, Song Y, Paulson EC, Roses RE, Fraker DL, Kelz RR, Miura J, Karakousis GC. Predictors of lymph node metastases in patients withvmucinous appendiceal adenocarcinoma. J Surg Oncol. 2020;1(8).

  31. Lam JY, McConnel Y, Rivard JD, Temple WJ, Mack LA. Hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis. Am J Surg. 2015;210:424–30.

  32. Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15: 2426–32.

  33. Pape UF, Niederle B, Costa F, et al. Vienna Consensus Conference participants. ENETS consensus guidelines for neuroendocrine neoplasms of the appendix (excluding goblet cell carcinomas). Neuroendocrinology. 2016;103:144–52.

  34. Ciarrocchi A, Pietroletti R, Carlei F, Amicucci G. Clinical significance of metastatic lymph nodes in the gut of patients with pure and mixed primary appendiceal carcinoids. Dis Colon Rectum. 2016;59:508–12.

  35. Nussbaum DP, Speicher PJ, Gulack BC, et al. Management of 1- to 2-cm carcinoid tumors of the appendix: using the national cancer data base to address controversies in general surgery. Am Coll Surg. 2015;220: 894–903.

  36. Singh S, Moody L, Chan DL, et al. Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) Follow-up Working Group. Follow-up recommendations for completely resected gastroenteropancreatic neuroendocrine tumors. JAMA Oncol. 2018;4: 1597–604.

  37. Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, Washington KM, Carneiro F, Cree IA; WHO Classification of Tumours Editorial Board. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020 Jan;76(2):182-188.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrea Ciarrocchi.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ciarrocchi, A., Rindi, G. & Pietroletti, R. Diagnosis and Treatment of Primary Tumors of the Appendix: a Critical Review. J Gastrointest Canc 52, 471–475 (2021). https://doi.org/10.1007/s12029-021-00628-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-021-00628-8

Keywords

Navigation